ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,610, issued on Nov. 4, was assigned to Korea University Research and Business Foundation (Seoul, South Korea).
"Pharmaceutical composition for treating or preventing diabetic cataract" was invented by Hong Seog Seo (Seoul, South Korea), Yong Jik Lee (Incheon, South Korea), Jong-Suk Song (Seoul, South Korea) and Youngsub Eom (Seoul, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a pharmaceutical composition for treating or preventing diabetic cataract, which contains midodrine or a pharmaceutically acceptable salt thereof as an active ingredient."
The patent was filed on Jan. 10, 2020, under Application N...